How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...
See our campus—from right where you are. Explore our campus from wherever you are in the world. You'll get an up-close look at areas such as Sears think[box], the Tinkham Veale University Center, our ...
Convicted killer Alex Murdaugh’s defense team has submitted its answer to prosecutors’ efforts to deny the disgraced former attorney a new murder trial. The man accused of being one of disgraced ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Suzanne is a content marketer, writer, ...
A judge in Minnesota is facing heat after she overturned a guilty verdict for an individual convicted in a $7.2 million fraud scheme that involved taxpayer money. Abdifatah Yusuf and his wife Lul ...
When you buy through our links, Business Insider may earn an affiliate commission. Learn more Though it typically costs $50 more than the digital-edition PS5, this model lets you play game discs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback